Abstract 9727: Long-Term Risks of Heart Failure and Atrial Fibrillation Following Adverse Pregnancy Outcomes: A Systematic Review and Meta-Analysis
Langzeitrisiken für Herzinsuffizienz und Vorhofflimmern nach adverse pregnancy outcomes: systematische Übersichtsarbeit und Metaanalyse
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.9727 ↗Auf einen Blick
Eine Metaanalyse von 47 Beobachtungsstudien mit 29,9 Millionen Frauen fand nach APOs erhöhte Langzeitrisiken für Herzinsuffizienz und Vorhofflimmern. Die Risiken hielten über Jahrzehnte nach der Entbindung an.
Fragestellung
Sind adverse pregnancy outcomes (APOs) mit erhöhten Langzeitrisiken für Herzinsuffizienz und Vorhofflimmern assoziiert, und bleiben diese Risiken über Jahrzehnte bestehen?
Methode
PRISMA-konforme systematische Übersichtsarbeit und Metaanalyse von Studien zu APOs und inzidenter Herzinsuffizienz oder Vorhofflimmern; Suche in PubMed, Embase, Scopus und Web of Science bis April 2026.
Ergebnisse
47 geeignete Beobachtungsstudien mit 29,9 Millionen Frauen. APOs: Herzinsuffizienz HR 1,52 (95 %-KI 1,24–1,85), Vorhofflimmern HR 1,39 (95 %-KI 1,24–1,56). HF-Risiko blieb nach 10–19, 20–29 und 30+ Jahren erhöht.
Schlussfolgerung der Autor:innen
In dieser ersten umfassenden Metaanalyse zu langfristigen maternalen kardiovaskulären Outcomes nach APOs waren HF und AF über mehr als drei Jahrzehnte postpartum erhöht; HDP war mit dem höchsten Risiko verbunden.
Kernaussagen
- APOs waren mit höherem Risiko für Herzinsuffizienz und Vorhofflimmern verbunden.
- Das Risiko blieb für Herzinsuffizienz über 30+ Jahre nach der Entbindung erhöht.
- HDP zeigte das höchste kardiovaskuläre Risiko, besonders bei schwerer/früher Präeklampsie.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Parvaneh Rastgou und 12 weiteren Autor:innen.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Adverse pregnancy outcomes (APOs) are established sex-specific cardiovascular risk factors. While individual cohort studies have linked specific APOs to heart failure (HF) and atrial fibrillation (AF), no prior meta-analysis has comprehensively quantified these risks across multiple APO phenotypes or examined their persistence over extended durations of follow-up. Research Question: Are APOs associated with increased long-term risks of HF and AF, and do these risks persist across decades of follow-up?
Methods
We performed a PRISMA-compliant systematic review and meta-analysis of studies evaluating associations between APOs and incident HF or AF. PubMed, Embase, Scopus, and Web of Science were systematically searched through April 2026.APOs included hypertensive disorders of pregnancy (HDP), gestational diabetes mellitus (GDM), preeclampsia, preterm delivery, small-for-gestational-age (SGA) birth, stillbirth, pregnancy loss, and composite APOs. Random-effects models were used to pool adjusted hazard ratios or odds ratios with 95% confidence intervals (CIs). Prespecified subgroup analyses were performed by APO subtype and duration of follow-up.
Results
We identified 47 eligible observational studies including 29.9 million women. APOs were associated with significantly increased long-term risks of HF (HR 1.52, 95% CI 1.24-1.85) and AF (HR 1.39, 95% CI 1.24-1.56). Among APO subtypes, HDP conferred the highest risk, particularly severe/early-onset preeclampsia (HR 4.82, 95% CI 1.33-17.46) and superimposed preeclampsia (HR 3.06, 95% CI 1.04-9.02). Preterm delivery (HR 1.69, 95% CI 1.47-1.94) and GDM (HR 1.42, 95% CI 1.03-1.96) were also associated with elevated HF risk. For AF, HDP (HR 1.56, 95% CI 1.22-2.00), gestational hypertension (HR 1.61, 95% CI 1.12-2.33), preeclampsia (HR 1.36, 95% CI 1.30-1.43), and chronic hypertension in pregnancy (HR 2.27, 95% CI 1.79-2.88) were associated with increased arrhythmic risk (Figure 2). In time-stratified analyses, HF risk remained significantly elevated at 10-19 years (HR 1.90, 95% CI 1.70-2.12), 20-29 years (HR 1.42, 95% CI 1.07-1.89), and 30+ years (HR 1.89, 95% CI 1.62-2.21) after delivery. AF risk similarly persisted across follow-up intervals: HR 1.55 (95% CI 1.32-1.81) at 10 years, HR 1.30 (95% CI 0.95-1.78) at 10-19 years, and HR 1.14 (95% CI 0.92-1.42) at 30+ years (Figure 3).
Conclusions
In this first comprehensive meta-analysis evaluating long-term maternal cardiovascular outcomes following APOs, APOs were associated with significantly elevated risks of both HF and AF persisting for more than three decades postpartum. HDP conferred the greatest cardiovascular risk, with severe/early-onset preeclampsia and superimposed preeclampsia more than tripling the long-term risk of HF.
Zitieren
APA
Rastgou, P., Servidoni, A. C. P., Callado, G. Y., Gawde, N., Surmann, H., Curi, B. C. B., Abdi, S., Abodabesh, S., Nezhad, S. A., Nanna, M., Hsueh, C., Tabtabai, S., & goldstein, S. (2026). Abstract 9727: Long-Term Risks of Heart Failure and Atrial Fibrillation Following Adverse Pregnancy Outcomes: A Systematic Review and Meta-Analysis. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.9727
Vancouver
Rastgou P, Servidoni ACP, Callado GY, Gawde N, Surmann H, Curi BCB, et al. Abstract 9727: Long-Term Risks of Heart Failure and Atrial Fibrillation Following Adverse Pregnancy Outcomes: A Systematic Review and Meta-Analysis. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.9727
BibTeX
@article{Rastgou2026,
author = {Rastgou, Parvaneh and Servidoni, Ana clara pimenta and Callado, Gustavo Yano and Gawde, Nimisha and Surmann, Hanna and Curi, Berenice Curi Berenice and Abdi, Sepideh and Abodabesh, Sara and Nezhad, Shefa Arya and Nanna, Michael and Hsueh, Christine and Tabtabai, Sara and goldstein, sarah},
title = {Abstract 9727: Long-Term Risks of Heart Failure and Atrial Fibrillation Following Adverse Pregnancy Outcomes: A Systematic Review and Meta-Analysis},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.9727}
}
EUVIMED